Targeting hepatocellular carcinoma heterogeneity with FAP and GPC3-specific tandem CAR-T cells
Saved in:
| Main Authors: | Dan Li, Wei Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | Molecular Therapy: Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950329924001012 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma
by: Linfu Zhou, et al.
Published: (2024-06-01) -
The molecular receptor NKBB enhances the persistence and anti-hepatocellular carcinoma activity of GPC3 CAR-T cells
by: Minghao Sui, et al.
Published: (2025-02-01) -
Impact of GPC3 rs2267531 Polymorphism on Hepatocellular Carcinoma Susceptibility
by: Batchimeg Batbaatar, et al.
Published: (2025-03-01) -
Targeting CD16A on NK cells and GPC3 in hepatocellular carcinoma: development and functional validation of a therapeutic bispecific antibody
by: Liu Chen, et al.
Published: (2025-06-01) -
Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapy
by: Yu Xu, et al.
Published: (2025-06-01)